As of August 28, 2026, Candel Therapeutics, Inc. (CADL) has a DilutionWatch DilutionScore of 27/100, rated MEDIUM dilution risk. Candel Therapeutics, Inc. has a market capitalization of $608.14M, 76.52M shares outstanding, 115 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $100.00M.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise
model 18%
• Active ATM program with $100M remaining capacity
Market Data
Market Cap$608.14M
Shares Outstanding76.52M
Float56.91M
Cash$201.56M
Debt$1.73M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 95.6% shares (2026Q1 vs prior)
115 institutional holders · 47.20M shares
#1
FMR LLC
10.99M shares
#2
RTW INVESTMENTS, LP
6.42M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
4.93M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest12.66M
Days to Cover10.4
% of Float22.2%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-12-31
4
INSIDER TRANSACTION
2026-04-02
4
INSIDER TRANSACTION
2026-04-02
4
INSIDER TRANSACTION
2026-04-02
4
INSIDER TRANSACTION
2026-02-26
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual CADL Dilution Snapshot
Candel Therapeutics, Inc. (CADL) has a DilutionScore of 27/100, rated Medium dilution risk. Score date: August 28, 2026.
- Stored ATM program remaining capacity: $100.0M.
- Recent SEC activity tracked for CADL: 4 on 2026-04-02; 4 on 2026-04-02; 4 on 2026-04-02.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track CADL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CADL — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for CADL
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.